FDA Clearance Tracker · K200898
Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas Glucose, Medicon Hellas Total Bilirubin, Medicon Hellas Direct Bilirubin
Last checked: Nov 19, 2026Latest source record: Sep 21, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Sep 21, 2021
Substantially Equivalent
Time to decision
536 days
Received Apr 3, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K200898
- Device name
- Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas Glucose, Medicon Hellas Total Bilirubin, Medicon Hellas Direct Bilirubin
- Applicant
- Medicon Hellas S.A
- Applicant location
- Gerakas, GR
- Received
- Apr 3, 2020
- Decided
- Sep 21, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Bromcresol Green Dye-Binding, Albumin (CIX)
- Device class
- Class II
- Regulation
- 21 CFR 862.1035
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CIX. The earliest in FDA's data is K760355, decided Oct 5, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K200898
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medicon Hellas S.A
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232404 · Decided Aug 9, 2024 · 365 days after receipt
Device type: Enzymatic Esterase--Oxidase, Cholesterol (CHH) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.